These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27558082)

  • 1. Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.
    Chan KL; van der Weyden C; Khoo C; Lade S; Blombery P; Westerman D; Khot A; Melo B; Johnstone RW; Prince HM; Dickinson M
    Leuk Lymphoma; 2017 Apr; 58(4):996-998. PubMed ID: 27558082
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study.
    Dupuis J; Morschhauser F; Ghesquières H; Tilly H; Casasnovas O; Thieblemont C; Ribrag V; Bossard C; Le Bras F; Bachy E; Hivert B; Nicolas-Virelizier E; Jardin F; Bastie JN; Amorim S; Lazarovici J; Martin A; Coiffier B
    Lancet Haematol; 2015 Apr; 2(4):e160-5. PubMed ID: 26687958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and treatment of peripheral T-cell lymphoma].
    Suzumiya J; Moriyama I; Kawakami K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
    [No Abstract]   [Full Text] [Related]  

  • 4. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study.
    Ellin F; Landström J; Jerkeman M; Relander T
    Blood; 2015 Jul; 126(1):36-41. PubMed ID: 25957393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.
    Otrock ZK; Hatoum HA; Salem ZM; Tawil A; Mahfouz RA; Zaatari GS; Bazarbachi A
    Ann Hematol; 2008 Dec; 87(12):1023-4. PubMed ID: 18587577
    [No Abstract]   [Full Text] [Related]  

  • 6. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.
    Wilhelm M; Smetak M; Reimer P; Geissinger E; Ruediger T; Metzner B; Schmitz N; Engert A; Schaefer-Eckart K; Birkmann J
    Blood Cancer J; 2016 Jul; 6(7):e452. PubMed ID: 27471868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
    Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
    [No Abstract]   [Full Text] [Related]  

  • 8. Point: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma: Where It Fits in the New Paradigm.
    Goy A
    Oncology (Williston Park); 2016 Dec; 30(12):1055-8, 1060. PubMed ID: 27987196
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing early failures with R-CHOP in patients with diffuse large B-cell lymphoma.
    Camus V; Tilly H
    Expert Rev Hematol; 2017 Dec; 10(12):1047-1055. PubMed ID: 27791447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
    Chihara D; Fowler NH; Oki Y; Fanale MA; Fayad LE; Westin JR; Hagemeister FB
    Br J Haematol; 2017 Dec; 179(5):851-854. PubMed ID: 27502933
    [No Abstract]   [Full Text] [Related]  

  • 11. Extranodal lymphoma: a reappraisal.
    Zucca E
    Ann Oncol; 2008 Jun; 19 Suppl 4():iv77-80. PubMed ID: 18519412
    [No Abstract]   [Full Text] [Related]  

  • 12. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
    Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
    Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to enrollment of patients with recurrent diffuse large B-cell lymphoma onto clinical trials.
    Marton A; Kezouh A; Petrogiannis-Haliotis T; Assouline S
    Leuk Lymphoma; 2015; 56(9):2747-9. PubMed ID: 25651426
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
    Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
    Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated central nervous system relapse in a patient with systemic diffuse large B-cell lymphoma: Diagnostic and treatment challenges.
    Das P; Dubashi B; Joseph D; Jain A
    Indian J Cancer; 2014; 51(4):468-9. PubMed ID: 26842164
    [No Abstract]   [Full Text] [Related]  

  • 16. Extranodal marginal zone B-cell lymphoma most probably of MALT type appearing in CNS as parasagittal extracerebral tumor.
    Marinković M; Slavik E; Janković S; Cemerikic V; Radulović D
    J Neurosurg Sci; 2006 Mar; 50(1):9-12. PubMed ID: 16557194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.
    Abe Y; Ohshima K; Shiratsuchi M; Honda K; Nishimura J; Nawata H; Muta K
    Eur J Haematol; 2001 Mar; 66(3):210-2. PubMed ID: 11350491
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete remission of primary cutaneous intravascular large B-cell lymphoma with R-CHOP followed by rituximab monotherapy.
    Pantelaki I; Tigges C; Nußbaum T; Oellig F; Wieland U; Kreuter A
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508527
    [No Abstract]   [Full Text] [Related]  

  • 19. Duvelisib as bridge to allotransplantation in refractory peripheral T-cell lymphoma with T-follicular helper phenotype: case report.
    Lolli G; Casadei B; Pellegrini C; Argnani L; Cocito F; Zinzani PL
    Tumori; 2021 Dec; 107(6):NP105-NP107. PubMed ID: 34167407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The first case report of composite bone marrow involvement by simultaneously developed peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma.
    Kim HK; Park CJ; Jang S; Cho YU; Park SH; Choi J; Park CS; Huh J; Chung YH; Lee JH
    Ann Lab Med; 2015 Jan; 35(1):152-4. PubMed ID: 25553299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.